Some find freedom from food noise. Others face new risks.

From ginger lozenges to psyllium fiber, these dietitian-approved products can help ease common digestive side effects while ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

The popularity of GLP-1 medication is soaring in the UK, but many people have been squeamish at the thought of injecting ...

And the conversation has moved well past "does it work." People are now asking a bigger question: if a huge chunk of the ...

Scientists believe the drugs may affect dopamine pathways in the brain — the chemical associated with pleasure and motivation by reducing the brain’s “reward drive” for food.

A new Medicare pilot program aims to expand access to GLP-1 weight loss medications, potentially reducing out-of-pocket costs ...

Roughly one in eight American adults is now taking a GLP-1 drug like Ozempic, Wegovy or Zepbound. The class traces back to a hormone isolated from Gila monster venom by a Bronx doctor who paid a ...

New reports on GLP-1 drugs and the brain’s “wanting” system have direct implications for how leaders motivate, reward, build ...

Around 2 million people in the UK are estimated to use weight loss drugs, and nearly 80 per cent of them are women. But new ...

Novo Nordisk A/S outlook: 2026 guidance warns revenue/profit declines as GLP-1 competition, pricing pressure & patent risks ...

New ACP guidelines recommend semaglutide and tirzepatide as first-line medications for adults with obesity alongside ...